HOME FORUMS BROKERS SOFTWARE BOOKS CONTACT US
Elite Trader Your Account  •  Become a Member  •  Help  •  Search    
    Forums ›› Main ›› Stocks ›› EXAS: Exact Sciences  


Post A Reply
    
Landis82
 

Registered: Jul 2006
Posts: 8580

 

10-07-12 06:25 PM

A very comprehensive article in Barron's this weekend on a huge growth stock with an excellent and proven management team . . .

http://online.barrons.com/article/S...mod=BOL_hps_mag

    Edit/Delete Quote Complain
Landis82
 

Registered: Jul 2006
Posts: 8580

 

10-27-12 08:48 PM

Quarterly Conference call this coming Tuesday.

The stock has sold off from the recent $12.30 high after the Barron's article and after the company reported 98% sensitivity with a 10% false-positive rate on 1003 samples in their "Cut-Off" study announced at the AACR conference week before last in Anaheim. After seeing this data, the analyst at Benchmark raised his price target to $17.

$9.41 is a screaming buy.

    Edit/Delete Quote Complain
Landis82
 

Registered: Jul 2006
Posts: 8580

 

12-10-12 03:00 PM

The Company has completed enrollment of 12,700 samples as of mid-November and should be processing those samples over the next 3 months thru 3 different labs (one of which is Mayo Clinic) with top-line FDA clinical trial results out in MARCH.

    Edit/Delete Quote Complain
Landis82
 

Registered: Jul 2006
Posts: 8580

 

12-11-12 11:20 PM

BIG MOVE TODAY UP TO $10.41

http://stockcharts.com/h-sc/ui?s=exas

Great looking chart!

    Edit/Delete Quote Complain
trefoil
 

Registered: Mar 2007
Posts: 3383

 

12-12-12 02:06 AM

So, how's about CYCC? I found this one trolling through the clinicaltrials.gov site. They just announced the results of a trial they did.
Ran it by my wife, who's an MD, and she seemed a bit skeptical. Figured I'd put it out there around here and see what the opinions are.

    Edit/Delete Quote Complain
Landis82
 

Registered: Jul 2006
Posts: 8580

 

01-18-13 04:29 PM

The FDA clinical trial for EXAS should be completed within a couple of months, with the top-line data from their "Deep-C" study announced in March.
The "Deep-C" FDA clinical trial will encompass 12,700 samples. The single biggest clinical trial ever attempted for a colon cancer screening test!

CRC is the #2 killer of Americans over the age of 50.
It costs Medicare $14 BILLION per year!

The manufacturing module was submitted back on December 7th.
The analytical module will be submitted in early February, with the final module... the clinical module submitted in March.

There is a parallel application to CMS/Medicare.
The Company will have CMS reimbursement within 90 days of FDA approval, instead of the usual 18-24 months that it has taken in the past, due to a new "fast-tracking" pilot-program that EXAS is involved in with CMS.

Buy the dips!

    Edit/Delete Quote Complain
    
Post A Reply


Receive an email whenever a new post is added to this thread by subscribing to it.
 
Rate This Thread:

Forum Jump:
 

 

   Conduct Rules  -  Privacy Policy  -  Day Trader -  Day Trader Forum -  Best Trading Software -  Sitemap Copyright © 2013, Elite Trader. All rights reserved.    
 
WHILE YOU'RE HERE, TAKE A MINUTE TO VISIT SOME OF OUR SPONSORS:
Advantage Futures
Futures Brokerage & Clearing
AMP Global Clearing
Futures and FX Trading
Bright Trading
Professional Equities Trading
CTS
Futures Trading Software
DaytradingBias.com
Professional Trading Analytics
ECHOtrade
Professional Trading Firm
eSignal
Trading Software Provider
FXCM
Forex Trading Services
Global Futures
Futures, Options & FX Trading
Interactive Brokers
Pro Gateway to World Markets
JC Trading Group
Direct Access Trading
MB Trading
Direct Access Trading
MultiCharts
Trading Software Provider
NinjaTrader
Trading Software Provider
OANDA
Currency Trading
optionshouse
Option Trading & Education
Rithmic
Futures Trade Execution Platform
SpeedTrader
Direct Access Trading
SpreadProfessor
Spread Trading Instruction
thinkorswim by TD Ameritrade
Direct Access TradingAdvertisement
TradersStudio
System Building & Backtesting
Trading Technologies
Trading Software Provider
Trend Following
Trading Systems Provider